How do hormonal changes affect depression risk in women?
They create windows of higher risk, and the body’s stress hormone system (the HPA axis) behaves differently in each one. Women are about twice as likely as men to develop depression, a gap that appears at puberty. In this 2023 review, depression tied to the menstrual cycle was linked to lower cortisol, depression in pregnancy and after birth was linked to higher cortisol, and depression in perimenopause showed little link to the HPA axis at all.
What the data show:
- Female-to-male depression ratio: About 2 to 1, a difference that emerges at puberty
- Premenstrual mood symptoms: About 20% of menstruating women have PMS with significant mood symptoms. Premenstrual dysphoric disorder (PMDD), the more severe depressive form, affects 3% to 8% of women of reproductive age
- Pregnancy: About 15% of pregnant women experience depression
- Postpartum depression: Affects about 12% of women with no prior history of depression
- Perimenopause risk: Depressive symptoms are reported by 45% to 68% of perimenopausal women, versus 28% to 31% before perimenopause. In three large US studies, the risk of depressive symptoms was about 30% to 55% higher in the early transition and about 70% to 190% higher in the late transition
- Vulnerable periods: The menstrual cycle, pregnancy, postpartum, and perimenopause all carry their own risk
- Mechanism: Estrogen and progesterone interact with the HPA axis in ways that are not fully mapped. The large hormone swings at each reproductive stage change how the stress system works, which is one reason these stages are windows of vulnerability
Dr. Kumar’s Take
The HPA axis is an important piece of the puzzle in women’s depression. The dramatic hormonal shifts women experience aren’t just “normal life events.” They are real biological challenges to the stress response system that may contribute to depression, although the link differs by stage and looks weak in perimenopause. The authors see this work as groundwork for future research on early diagnosis and treatment targets. For now, it helps validate women’s experiences of mood changes during reproductive transitions.
What the Research Shows
HPA axis function changes across women’s reproductive stages, but its link to depression is not the same at each stage. Some evidence links altered cortisol patterns to premenstrual (PMDD) and perinatal depression, though for PMDD some studies found no difference from controls. For perimenopausal depression, the available data do not support a role for HPA axis dysregulation.
Study Snapshot
This 2023 narrative review pulled together research on HPA axis function in depression at three reproductive stages: the menstrual cycle, pregnancy and the postpartum period, and perimenopause. It examined cortisol levels, daily cortisol rhythm, and cortisol response to stress at each stage, and how a history of stress and trauma feeds into depression risk.
Results in Real Numbers
Key findings about the HPA axis and women’s depression:
- Menstrual cycle: In healthy women, resting cortisol is higher in the follicular phase than the luteal phase, but the cortisol response to stress is higher in the luteal phase. Women with PMDD tend to have lower cortisol at rest and a blunted cortisol response to stress in both phases, though some studies found no difference
- Pregnancy: By the third trimester, cortisol is 2 to 3 times higher than in women who are not pregnant, then falls sharply after delivery
- Perinatal depression: Women with depression in pregnancy or after birth tend to have higher cortisol, a flatter daily cortisol rhythm, and a weaker cortisol response to acute stress
- Perimenopause: Cortisol rises in late perimenopause, but this rise was not tied to mood. The available data do not support HPA axis dysregulation as a cause of perimenopausal depression
- Trauma: Early and lifetime trauma was linked to depression at every reproductive stage. In one large Swedish study, women reporting 5 or more adverse childhood experiences had a 4.2-fold higher risk of depression during pregnancy
How This Works (Biological Rationale)
The HPA axis runs the stress response: the hypothalamus signals the pituitary gland, which signals the adrenal glands to release cortisol. Estrogen and progesterone interact with this system in both directions, and those interactions are not fully understood. In the luteal phase, a progesterone byproduct called allopregnanolone is thought to hold resting cortisol down. In pregnancy, the placenta drives cortisol up. Each reproductive transition brings large hormone shifts that change how the stress system responds, and the pattern of change differs from one stage to the next.
Why This Matters for Health and Performance
Understanding HPA axis changes across reproductive stages helps explain:
- Timing of depression onset in women often coincides with hormonal transitions
- Symptom patterns that may fluctuate with menstrual cycles or life stages
- Prevention opportunities during high-risk reproductive transitions
- Future research directions, since the authors expect that accounting for individual hormonal sensitivity will eventually support personalized treatment
Practical Takeaways
- Track mood patterns in relation to menstrual cycles to identify hormonal influences
- Anticipate vulnerable periods during reproductive transitions and plan support accordingly
- Mention your reproductive stage to your clinician, since timing can matter when mood changes
- Support stress management during high-risk periods like postpartum and perimenopause
- Validate hormonal influences on mood rather than dismissing them as “just hormones”
- Collaborate with reproductive health specialists for comprehensive care during transitions
Related Studies and Research
Episode 31: Depression Explained, The Biology Behind the Darkness
Episode 32: Depression Recovery Roadmap: A Step-by-Step, Evidence-Based Plan
FAQs
Why are women more susceptible to depression than men?
Women are roughly twice as likely as men to develop depression. The mechanisms behind that remain obscure, and HPA axis dysregulation is one that has drawn substantial attention rather than an established cause. Estrogen and progesterone fluctuations create periods of vulnerability that men don’t experience.
Can hormone therapy help with depression during reproductive transitions?
Hormone therapy may help some women, particularly during perimenopause, but should be carefully considered with healthcare providers as benefits and risks vary individually.
How can women prepare for high-risk periods like postpartum or menopause?
Preparation includes stress management skills, social support systems, monitoring for early symptoms, and establishing relationships with mental health providers before transitions occur.
Bottom Line
The HPA axis changes across women’s reproductive lifecycle, and its link to depression differs by stage. Menstrual-cycle depression was tied to lower cortisol and perinatal depression to higher cortisol, while the data do not support a role for the HPA axis in perimenopausal depression. The authors frame these patterns as a guide for future research into early diagnosis and treatment targets, not yet as a basis for personalized treatment.
